Related Experiment Video
Updated: Dec 14, 2025

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
Published on: March 1, 2022
Methodological aspects of superiority, equivalence, and non-inferiority trials
Roumeliotis Stefanos1,2, D 'Arrigo Graziella3, Tripepi Giovanni3
1Division of Nephrology and Hypertension, 1st Department of Internal Medicine, School of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, St. Kyriakidi 1, 54636, Thessaloniki, Greece. st_roumeliotis@Hotmail.com.
Abstract:
Depending on the scientific hypothesis to be addressed, randomized-controlled trials (RCT) are accordingly designed. RCTs that aim to determine whether a novel, experimental therapeutic intervention (either a drug or a treatment) is superior to a placebo or control intervention, are called superiority trials. Less common are the non-inferiority RCTs, designed to assess whether a new intervention is not unacceptably worse than an already existing reference intervention. An equivalence RCT is designed to investigate whether a novel treatment is equivalently effective to another, already existing, control intervention. In equivalence and non-inferiority RCTs, the efficacy of the reference intervention (active comparator) is already established, and therefore, an untreated control group would not be ethical. In this review, using a series of examples derived from equivalence and non-inferiority/superiority RCTs, we describe the main differences and methodological aspects among these three different types of RCTs.
Insights
This review clarifies the distinctions between superiority, non-inferiority, and equivalence randomized controlled trials (RCTs). Understanding these trial designs is crucial for evaluating new therapeutic interventions and ensuring ethical research practices.
Area of Science:
- Clinical Trials Methodology
- Evidence-Based Medicine
Background:
- Randomized controlled trials (RCTs) are fundamental in medical research.
- Different hypotheses necessitate distinct RCT designs, impacting interpretation of results.
Purpose of the Study:
- To delineate the key differences between superiority, non-inferiority, and equivalence RCTs.
- To illustrate methodological aspects using practical examples from clinical research.
Main Methods:
- Review of existing literature on RCT designs.
- Analysis of case examples from superiority, non-inferiority, and equivalence trials.
- Comparative description of trial objectives and ethical considerations.
Main Results:
- Superiority trials test if a new intervention is better than a control.
- Non-inferiority trials assess if a new intervention is not unacceptably worse than a reference.
- Equivalence trials determine if a new intervention is similarly effective to a reference.
Conclusions:
- The choice of RCT design (superiority, non-inferiority, or equivalence) is dictated by the research question.
- Ethical considerations, particularly regarding untreated control groups, differ across trial types.
- Accurate understanding of these designs is vital for interpreting therapeutic intervention studies.
Related Concept Videos
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
One-Way ANOVA: Equal Sample Sizes
Different sample means can result in different values for the variance estimate: variance between samples. This is because the variance between samples is calculated as the product of the sample size and the variance between the...
Comparing Experimental Results: Student's t-Test
Friedman Two-way Analysis of Variance by Ranks
One-Way ANOVA: Unequal Sample Sizes

